コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s activity as the prototype type III protein arginine methyltransferase.
2 ated an enzyme-dead knock-in of this protein arginine methyltransferase.
3 s impaired and is proposed to function as an arginine methyltransferase.
4 ally interacts with PRMT1, the major protein arginine methyltransferase.
5 product specificity displayed by the protein-arginine methyltransferases.
6 on of an array of substrates for the protein arginine methyltransferases.
7 tinguishes PRMT7 from all of the other known arginine methyltransferases.
8 ginine methylation mediated by the family of arginine methyltransferases.
9 ase, and is derived by the action of protein-arginine-methyltransferases.
10 subject to E2-induced coactivator-associated arginine methyltransferase 1 (CARM1) action are critical
12 ic phosphorylation of coactivator-associated arginine methyltransferase 1 (CARM1) and prevents its co
13 cells by the methyltransferases coactivator arginine methyltransferase 1 (CARM1) and protein arginin
14 Here we identify co-activator-associated arginine methyltransferase 1 (CARM1) as a crucial compon
23 ere, we identify that coactivator-associated arginine methyltransferase 1 (CARM1) methylates Pontin c
25 one such cofactor as coactivator-associated arginine methyltransferase 1 (CARM1), a unique coactivat
26 substrates induced by coactivator-associated arginine methyltransferase 1 (CARM1), both in in vitro a
27 eta-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight
29 demonstrate that the coactivator-associated arginine methyltransferase 1 (CARM1), which methylates h
33 lycogen synthase kinase 3 (GSK3) and protein arginine methyltransferase 1 (PRMT-1) cooperate to orche
36 2F-1 by the asymmetric dimethylating protein arginine methyltransferase 1 (PRMT1) and symmetric dimet
40 activity of RIP140 was suppressed by protein arginine methyltransferase 1 (PRMT1) due to RIP140 methy
41 of the EGFR extracellular domain by protein arginine methyltransferase 1 (PRMT1) enhances binding to
48 d receptor coactivator 1 (SRC1), and protein arginine methyltransferase 1 (PRMT1) only modestly incre
49 e major arginine methylation enzyme, protein arginine methyltransferase 1 (PRMT1) strictly generates
51 tentiated by arginine methylation by protein arginine methyltransferase 1 (PRMT1), another nuclear re
52 class 1 arginine methyltransferase, protein arginine methyltransferase 1 (PRMT1), regulates nucleocy
54 nt signaling through the activity of protein arginine methyltransferase 1 (PRMT1), which transfers on
57 ating protein G3BP1 is methylated by protein arginine methyltransferase 1 and 5 (PRMT1 and PRMT5).
58 s as an enhancer for the assembly of protein arginine methyltransferase 1 and the protein arginine me
59 tein methylation and coexpression of protein arginine methyltransferase 1 did not influence Nox activ
63 ic dimethyl H4R3 catalyzed by PRMT1 (protein arginine methyltransferase 1) facilitates histone H3 ace
64 hyltransferase CARM1 (coactivator-associated arginine methyltransferase 1) promotes the nuclear expor
68 protein K (hnRNP K) protein by human protein arginine methyltransferase 1, variant 1 (hPRMT1v1), in j
70 arginine methyltransferase 1 and the protein arginine methyltransferase 1-linked histone 4 arginine 3
71 tase-transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, a
73 e protein expression was reduced and protein-arginine-methyltransferase-1 increased in alcoholic hepa
77 ocardial infarction, the PRMT3 gene (protein arginine methyltransferase 3) with stroke, and the LHFPL
78 rt a novel regulation of pRb through protein arginine methyltransferase 4 (PRMT4)-mediated arginine m
80 P) confers a selective dependence on protein arginine methyltransferase 5 (PRMT5) and its binding par
81 requires assembly factors united in protein arginine methyltransferase 5 (PRMT5) and survival motor
82 characterization of a complex of the protein arginine methyltransferase 5 (Prmt5) and the methylosome
83 PDCD4 in breast cancer and identify protein arginine methyltransferase 5 (PRMT5) as a cofactor that
84 e describe the identification of the protein arginine methyltransferase 5 (PRMT5) as an effector recr
85 on and mass spectrometry to identify protein arginine methyltransferase 5 (PRMT5) as part of the p38d
96 e suggest that the methyltransferase protein arginine methyltransferase 5 (PRMT5) is responsible for
98 kinases (M6CKs) bind subunits of the protein arginine methyltransferase 5 (PRMT5) molecular complex t
100 uppressor, but its coexpression with protein arginine methyltransferase 5 (PRMT5) promotes accelerate
101 rmation to document the relevance of protein arginine methyltransferase 5 (PRMT5) to regulation of ep
105 ar ribonucleoprotein D3b (SmD3b) and protein arginine methyltransferase 5 (PRMT5), which are required
111 genetic analysis we demonstrate that protein arginine methyltransferase 5 (PRMT5; At4g31120) is a cri
112 F-1 is directly methylated by PRMT5 (protein arginine methyltransferase 5), and that arginine methyla
114 e known Ajuba binding partner Prmt5 (protein arginine methyltransferase-5) inhibited the Ajuba/RAR in
115 nine methyltransferase 1 (CARM1) and protein arginine methyltransferase 6 (PRMT6) in vitro and in viv
124 ssociated with blunted expression of protein arginine methyltransferase 7 (Prmt7) on chromosome 8, a
126 ound that the selective inhibitor of protein arginine methyltransferases 7,7'-carbonylbis(azanediyl)b
129 ide an example for the regulation of protein arginine methyltransferase activity by phosphorylation.
130 identical to human PRMT1, the major protein arginine methyltransferase activity in mammalian cells.
131 recruitment of CARM1 not only adds a protein arginine methyltransferase activity to the ER-coactivato
133 stingly, loss of PRMT1, the major asymmetric arginine methyltransferase, also sensitizes cells to PRM
134 ine methyltransferase 1 (CARM1), the histone arginine methyltransferase and coactivator for many tran
135 strate that the activity of PRMT5, a protein arginine methyltransferase and indirect target of CDK4,
136 PRMT3 as the first type I ribosomal protein arginine methyltransferase and suggest that it regulates
137 icity and the catalytic mechanism of protein arginine methyltransferases and have important implicati
138 Cell, comprehensively examined the nature of arginine methyltransferases and histone modifications in
141 showed that the Arabidopsis thaliana protein arginine methyltransferase AtPRMT3 regulates pre-rRNA pr
142 methyltransferase 1 (PRMT1), the predominant arginine methyltransferase, can act as a transcriptional
143 K6/K16 repression involved beta-catenin and arginine methyltransferase (CARM-1) acting as co-repress
144 how one mechanism of such regulation via the arginine methyltransferase CARM1 (coactivator-associated
146 prediction by overexpressing the H3-specific arginine methyltransferase CARM1 in individual blastomer
150 ed the requirement for Prmt5 and the class I arginine methyltransferase Carm1/Prmt4 in the temporal c
151 found that a small molecule inhibitor of the arginine methyltransferases CARM1 and PRMT6 was able to
152 one methyltransferase coactivator-associated arginine methyltransferase (CARM1) depends on the methyl
154 ne methyltransferase, coactivator-associated arginine methyltransferase (CARM1/PRMT4), during IFN-gam
158 anscription and synergy is abrogated when an arginine methyltransferase-defective CARM1 mutant is use
163 four other representative histone lysine and arginine methyltransferases, G9a, SUV39H1, PRMT1 and CAR
166 cetylases, BET bromodomain proteins, protein arginine methyltransferases, histone lysine methyltransf
168 Previously, we demonstrated that the protein arginine methyltransferase Hmt1 plays a role in the form
170 Liao et al. investigate the role of protein arginine methyltransferase I (PRMT1) in regulating EGFR
171 an important functional role of this histone arginine methyltransferase in reprogramming ERalpha-regu
174 Our data show that Hmt1, the major type I arginine methyltransferase, methylates Snp1, a U1 small
176 It is the first to demonstrate that protein arginine methyltransferases participate in the DNA methy
177 ted on specific arginine residues by protein arginine methyltransferase (PRMT) 1 and PRMT5 in its RGG
182 However, a conclusive role for the protein arginine methyltransferase (PRMT) enzymes that catalyze
183 sferase 1 (CARM1) is a member of the protein arginine methyltransferase (PRMT) family and methylates
184 e completely conserved in the type I protein arginine methyltransferase (PRMT) family of enzymes.
185 A1b proteins by three members of the protein arginine methyltransferase (PRMT) family: PRMT1, PRMT3,
187 panosoma brucei PRMT7 (TbPRMT7) is a protein arginine methyltransferase (PRMT) that strictly monometh
189 ctrometry identified LRP6 binding to protein arginine methyltransferase (PRMT)-1, and nuclear asymmet
191 d colleagues demonstrate that type I protein arginine methyltransferases (PRMT) are directly involved
193 oter through the interaction of YY1 with the arginine methyltransferase PRMT1 and evidence of its act
194 lls induced rapid ERalpha methylation by the arginine methyltransferase PRMT1 and triggered the bindi
196 h an shRNA screen, we identified the protein arginine methyltransferase Prmt1 as a vulnerable interve
197 tified as inhibitors against the predominant arginine methyltransferase PRMT1 within micromolar poten
198 RUNX1 is arginine-methylated in vivo by the arginine methyltransferase PRMT1, and that PRMT1 serves
199 ignaling increased expression of the protein arginine methyltransferase PRMT1, which in turn methylat
200 , RACO-1 is identified as a substrate of the arginine methyltransferase PRMT1, which methylates RACO-
201 te (1) the additional involvement of protein arginine methyltransferases PRMT1 and CARM1 in p53 funct
202 how that S-HDAg can be methylated by protein arginine methyltransferase (PRMT1) in vitro and in vivo.
203 uman genome encodes a family of nine protein arginine methyltransferases (PRMT1-9), whose members can
204 re-activated mouse models of three different arginine methyltransferases, PRMT1, CARM1, and PRMT6, wh
206 m an extraribosomal complex with the protein arginine methyltransferase PRMT3 that is conserved from
207 tional analysis, we demonstrate that protein arginine methyltransferase PRMT4 (CARM1) methylates TP2
209 the selective overexpression of the protein arginine methyltransferase PRMT5 as a novel candidate th
210 ponents and identify the ortholog of protein arginine methyltransferase PRMT5 as the enzyme responsib
211 d enhanced expression of the type II protein arginine methyltransferase PRMT5 as well as the polycomb
216 g the target genes, we confirmed the protein arginine methyltransferase Prmt5 is a direct target that
220 of Cancer Cell, Braun et al. report that the arginine methyltransferase PRMT5 is critical for tumor c
224 histone acetyltransferase 1 and the histone arginine methyltransferase PRMT5 was decreased by 17AAG.
226 We previously demonstrated that the class II arginine methyltransferase Prmt5 was required for skelet
229 Epigenetic regulation by the type II protein arginine methyltransferase, PRMT5, plays an essential ro
230 functionally analyzed two different protein arginine methyltransferases, Prmt5 and Prmt4, both of wh
231 rom degradation, with methylation of GPS2 by arginine methyltransferase PRMT6 regulating the interact
233 oexpression of Nav1.2 with the primary brain arginine methyltransferase PRMT8 led to a surprising 3-f
234 ng flagellar dynamics, we focused on protein arginine methyltransferases (PRMTs) 1, 3, 5, and 10.
237 s methylated on arginine residues by protein arginine methyltransferases (PRMTs) and is degraded by d
244 haracterized selective inhibitors of protein arginine methyltransferases (PRMTs) are invaluable chemi
251 Covalent modification of histones by protein arginine methyltransferases (PRMTs) impacts genome organ
252 sine methyltransferases (HKMTs), and protein arginine methyltransferases (PRMTs) in pancreatic alpha-
257 genetic modification of chromatin by protein arginine methyltransferases (PRMTs) is crucial for norma
263 ification in eukaryotes catalyzed by protein arginine methyltransferases (PRMTs) that are typically t
265 ginine, mediated by PRMT5 and type I protein arginine methyltransferases (PRMTs), respectively, reduc
268 es aimed at blocking the activity of protein arginine methyltransferases (PRMTs), which catalyze the
274 c arginine methylation of FUS by the class 1 arginine methyltransferase, protein arginine methyltrans
275 on of protein methyltransferases, especially arginine methyltransferases, relieve the repression of E
276 Depletion of PRMT5, the primary protein arginine methyltransferase responsible for symmetric arg
277 and colleagues report that CARM1, a protein arginine methyltransferase, specifically methylates BAF1
279 tion of the major trypanosome type 1 protein arginine methyltransferase, TbPRMT1, disrupts formation
282 ooperate with PRMT1, a CARM1-related protein arginine methyltransferase that also functions as an NR
283 C1 recruits the chromatin modifier PRMT5, an arginine methyltransferase that catalyzes symmetric dime
285 inine methyltransferase 5 (PRMT5), a protein arginine methyltransferase that catalyzes the symmetrica
287 ne methyltransferase 10 (PRMT10) is a type I arginine methyltransferase that is essential for regulat
289 ine methyltransferase 1 (CARM1) is a protein arginine methyltransferase that methylates histones and
292 n arginine methyltransferase 5 (PRMT5) is an arginine methyltransferase that symmetrically dimethylat
294 we show that UHRF1 interacts with PRMT5, an arginine methyltransferase, to regulate the repressive h
296 ates suggest that type I and type II protein-arginine methyltransferases use distinct molecular deter
297 ly modulates enzymatic activity of a protein arginine methyltransferase vital to abiotic stress toler
298 IL-4 upregulates the expression of protein arginine methyltransferases, which are essential for ADM